Hypertension and Diabetes Assessment in the Rohingya Refugee Population and in the Host Communities in Bangladesh
Hypertension and Diabetes Mellitus Assessment in the Rohingya Refugee Population and in the Host Communities in Bangladesh
1 other identifier
observational
3,000
0 countries
N/A
Brief Summary
Due to a massive outbreak of violence against the Rohingya minority residing in the Rakhine State of Myanmar in late 2017, several hundred thousand Rohingya fled the country and sought a shelter in Bangladesh. Currently, in the refugee settlement areas east of the city of Cox's Bazar, close to 1 million Rohingya refugees live in refugee camps close to the municipalities of Ukhia and Shamlapur. According to previous examinations, there is a serious burden of non-communicable diseases in Bangladesh. But little is known about the health status and the epidemiology of non-communicable diseases in the Rohingya refugee population in Bangladesh. Most importantly, scientific evidence on non-communicable disease in humanitarian emergencies is rather limited. The aim of this study is to close this gap and to systematically assess the burden of hypertension and diabetes within the Rohingya refugee population in refugee camps in Bangladesh and in the host community in the Chittagong province. This assessment will help to design and to introduce community-based intervention strategies aiming to improve the population health status and reduce the disease burden.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2021
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 11, 2020
CompletedFirst Posted
Study publicly available on registry
March 13, 2020
CompletedStudy Start
First participant enrolled
October 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2022
CompletedApril 28, 2021
April 1, 2021
8 months
March 11, 2020
April 27, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of hypertension
Assessment of the prevalence of hypertension in the study groups
04-06/2020
Secondary Outcomes (9)
Prevalence of diabetes mellitus
04-06/2020
Mean systolic BP
04-06/2020
Mean fasting plasma glucose
04-06/2020
Successful BP treatment
04-06/2020
Successful diabetes treatment
04-06/2020
- +4 more secondary outcomes
Study Arms (2)
Rohingya refugee camp population
A sample of 1500 randomly selected individuals aged 18 years and above living in the Rohingya refugee camp 1E.
Shamlapur refugee hosting community population
A sample of 1500 randomly selected individuals aged 18 years and above living in the refugee hosting community Shamlapur neighbouring the Rohingya refugee camps.
Interventions
measuring blood pressure with standard sphygmomanometer
measuring blood glucose using standard measurement devices
WHODAS 2.0, PHQ-9, CAPS-5
Eligibility Criteria
The study population will be a random household sample from Camp 1E at the Cox's Bazar refugee camp area in Bangladesh and a random household sample from the Bangladesh host community in Shamlapur. Camp 1E is located on the northern end of the Cox's Bazar refugee camp area near Ukhia in south-eastern Bangladesh. Shamlapur is a village on the shores of the golf of Bengal, located about 25 kilometers south of Camp 1E. The population of Camp 1E is 40,000, half of them children under 18 years of age. The average household size is 4 people.
You may qualify if:
- Residing in one of the selected households (Camp 1E or Shamlapur municipality)
- Age ≥18 years
You may not qualify if:
- Inability to provide written informed consent
- Participant's unwillingness to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital Freiburglead
- Heidelberg Universitycollaborator
- Gono Bishwabidyalaycollaborator
- Gonoshasthaya Kendracollaborator
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kashem Shaikh, PhD
Gono Bishwabidyalay
- PRINCIPAL INVESTIGATOR
Alexander Supady, Dr. med. MPH
University of Freiburg
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Attending Physician
Study Record Dates
First Submitted
March 11, 2020
First Posted
March 13, 2020
Study Start
October 1, 2021
Primary Completion
May 15, 2022
Study Completion
September 30, 2022
Last Updated
April 28, 2021
Record last verified: 2021-04